Used in pharmaceutical research as a key intermediate for developing central nervous system agents, particularly in the synthesis of compounds targeting neurological disorders such as anxiety, depression, and schizophrenia. Shows potential in the development of selective receptor modulators due to its structural affinity for binding to serotonin and dopamine receptors. Also explored in the design of novel analgesics and cognitive enhancers. Its scaffold is valued in medicinal chemistry for improving metabolic stability and blood-brain barrier penetration in drug candidates.